Domestic short-haired cats (age 6–12 months, weight 2.0–5.0 kg) underwent surgery. After sedation with ketamine (20 mg/kg) and xylazine (0.5 mg/kg), each animal was intubated and anesthetized with isoflurane. The pupil was dilated with 1% tropicamide. The animal was placed under a surgical microscope (URBAN; Storz, St. Louis, MO). Globe exposure was increased by lateral canthotomy, and the superonasal and temporal quadrants were exposed by 240° conjunctival peritomy. Pars plana incisions were made 4 mm posterior to the limbus with a 20-gauge blade (V-lance; Alcon Surgical, Fort Worth, TX) in both superior quadrants and inferotemporally. An infusion cannula (3 mm in length) was introduced through the inferotemporal sclerotomy and secured with a 4-0 silk mattress suture. Balanced saline solution (BSS; Alcon Surgical) was infused into the vitreous cavity. A light pipe and vitrectomy probe (Ocutome; Alcon Surgical) were introduced through the superior sclerotomies, and a contact lens was applied to the cornea. After pars plana lensectomy and core vitrectomy, the infusion solution was changed from saline solution to saline solution without Ca2+ to facilitate retinal detachment without damage to the RPE. The infusion fluid was again changed after 20 minutes to saline solution containing calcium. A 39-gauge cannula (Storz) attached to a 50-mL syringe was positioned against the pigmented area of the retina by the surgeon. A syringe pump (SP 100I; World Precision Instruments, Sarasota, FL) injected saline solution (40 mL/h) to create a controlled retinal detachment approximately 4 mm in diameter. A 30-gauge cannula connected to a 100 μL syringe (Hamilton, Reno, NV) was used to inject AAV-GFP (20 μL, 1 × 1013 particles/mL) slowly into the subretinal space through the retinotomy. Sclerotomies, conjunctival incisions, and the canthotomy were closed with 7-0 nylon sutures (Vicryl; Ethicon, Somerville, NJ). Dexamethasone sodium phosphate (1.2 mg) and gentamicin (12 mg) were injected subconjunctivally, and the eye was dressed with 1% chloramphenicol, 0.3% tobramycin, 0.1% dexamethasone, and 1% atropine ophthalmic ointment.
Initial studies were performed to determine the time of peak expression of GFP. Fundus photographs using fluorescein filters were taken to monitor expression of GFP. Four animals were observed at 1-week intervals for up to 8 weeks after injection. These studies showed peak expression at 5 weeks, and expression lessened at 6 weeks or more
(Fig. 1) . Because in vitro studies suggested the possibility that light from serial photography may cause RPE toxicity (see the Results section), seven animals were monitored at 5 weeks only, to confirm expression of GFP immediately before they were killed for histology and immunocytochemistry studies, cell culture, or transplantation.
Experimental eyes from two animals were harvested specifically to isolate transduced cells for culture. Of the five remaining eyes included in this study, three were killed and processed for analysis by histology and immunocytochemistry, and two served as donors for RPE transplantation experiments.